Thus, elucidation of the molecular mechanism underlying such regulatory pathways may contribute to achieving a further enhancement of functional NIS expression in extrathyroidal cancer tissues, expanding the application of radioiodide therapy to all NIS-expressing neoplasia. Here, SLC5A5 is linked to cancer.